Moderna, BioNTech And Some Other Big Stocks Moving Higher On Wednesday

U.S. stocks traded mostly higher, with the Dow Jones gaining more than 100 points on Wednesday. Here are some big stocks recording gains in today’s session.

• FLJ Group Limited (NASDAQ:FLJ) shares jumped 69% to $2.59.
• Cango Inc. (NYSE:CANG) climbed 13.1% to $2.5550 after the company declared a special cash dividend of $0.50 per share.
• El Pollo Loco Holdings, Inc. (NASDAQ:LOCO) rose 12.7% to $10.26 after the company declared a special dividend of $1.50 per share and approved a 20 million share buyback program.
• KnowBe4, Inc. (NASDAQ:KNBE) rose 12.6% to $24.32 after the company announced it will be acquired by Vista Equity Partners for $4.6 billion.
• RLX Technology Inc. (NYSE:RLX) surged 11.5% to $1.11. RLX recently reported a second-quarter FY22 sales decline of 12% year-on-year to $333.50 million.
• Moderna, Inc. (NASDAQ:MRNA) gained 10% to $132.78. Moderna said Merck & Co had exercised an option to jointly develop and potentially sell personalized mRNA-based cancer vaccine. The FDA also authorized Moderna and Pfizer-BioNTech bivalent Covid-19 vaccines for use as a booster dose in younger age groups.
• AMTD Digital Inc. (NYSE:HKD) rose 9.4% to $45.07 after jumping 35% on Tuesday.
• AZZ Inc. (NYSE:AZZ) gained 8.8% to $33.09. AZZ, on Tuesday, reported worse-than-expected Q2 adjusted EPS results. The company said it will not issue full-year fiscal year 2023 guidance at this time.
• FiscalNote Holdings, Inc. (NYSE:NOTE) gained 7.1% to $5.34.
• Pacific Biosciences of California, Inc. (NASDAQ:PACB) surged 6.5% to $6.04.
• United Microelectronics Corporation (NYSE:UMC) gained 5.8% to $5.67.
• BioNTech SE (NASDAQ:BNTX) gained 5.5% to $136.62. Pfizer and BioNTech received U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine booster in children 5 through 11 years of age.